Correction: Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

Affiliations

• ¹ Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga, s/n, Hospitalet de Llobregat, Barcelona, 08907, Spain. fjnarvaez@bellvitgehospital.cat.
• ² Department of Rheumatology, Hospital Cl?nico, Universitario Lozano Blesa, Zaragoza, Spain.
• ³ Department of Rheumatology. Hospital, Universitario de la Santa Creu i Sant Pau, Barcelona, Spain.
• ⁴ Department of Rheumatology. Hospital, Universitario Dr Peset, Valencia, Spain.
• ⁵ Interstitial Lung Disease Unit, Department of Pneumology. Hospital, Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
• ⁶ Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga, s/n, Hospitalet de Llobregat, Barcelona, 08907, Spain.